Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study.

Buti, Sebastiano; Donini, Maddalena; Bersanelli, Melissa; Gattara, Alessia; Leonardi, Francesco; Passalacqua, Rodolfo

Buti, Sebastiano; Donini, Maddalena; Bersanelli, Melissa; Gattara, Alessia; Leonardi, Francesco; Passalacqua, Rodolfo.

Afiliación

Buti S; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
Donini M; Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Cremona, Italy.
Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy. bersamel@libero.it.
Gattara A; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
Leonardi F; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
Passalacqua R; Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Cremona, Italy.

Drugs R D ; 18(2): 163, 2018 06.

Article en En | MEDLINE | ID: mdl-29808389

ABSTRACT

ABSTRACT

In the Original Publication of the article, In Introduction part, 7th line, the value "5-100nM" has been published incorrectly. The correct value should read as "Plasma concentration of 50-100ng/ml". In the Original Publication of the article, page 591, Table 2 has been published incorrectly. The corrected table is shown in the following page.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Drugs R D Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google